Endoceutics site # 02

Québec, Quebec G1S 2L6

0 studies enrolling now · 5 studies all time

What they study most

Hypoactive Sexual Desire Disorder, Vaginal Atrophy

Studies at this site

• Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) — Completed
• DHEA Against Vaginal Atrophy - Safety Study of 12 Months — Completed
• DHEA Against Vaginal Atrophy - 3-Month Efficacy Study — Completed
• Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy — Completed
• Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause — Completed